Population screening requires robust evidence-genomics is no exception
- PMID: 38070525
- DOI: 10.1016/S0140-6736(23)02295-X
Population screening requires robust evidence-genomics is no exception
Conflict of interest statement
Declaration of interests HVF acknowledges former chairing of the Joint Committee on Genomics in Medicine for the Royal Colleges 2018–22, and royalties from UpToDate (as a Section Editor in Genetics). RL acknowledges membership of the Foetal Maternal and Child Health Group of the UK National Screening Committee. MM acknowledges membership of a steering group for the 2024 St Andrews Evidence Based Early Diagnosis conference. AOMW acknowledges non-remunerated roles on the Science Advisory Committee of Genomics England and the Medical Research Council Molecular and Cellular Medicine Board. SW acknowledges non-financial support from Illumina (outside of the submitted work). All other authors declare no competing interests.
Comment in
-
Low-value population screening.Lancet. 2024 Sep 7;404(10456):935. doi: 10.1016/S0140-6736(24)01688-X. Lancet. 2024. PMID: 39244272 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
